Phraxis: Funding, Investors & Team (Oct 2026)
Phraxis is a medical device company, develops treatment solutions for patients who need vascular access to enable hemodialysis. The company offers InterGraft, a percutaneously delivered arterio-venous shunt that provides a non-surgical approach for patients who need vascular access. It also develops devices for interventional nephrology to enable physicians to manage their dialysis patients. The company was incorporated in 2008 and is based in St. Paul, Minnesota.
Phraxis has raised $4.5M across 1 funding round on record, the most recent a Series D of $4.5M announced in Mar 2022.
That round is in line with the $4.9M median round size for Health Care companies tracked on FundedIQ over the last two years.
Phraxis Company Profile and Key Stats
Latest funding round on record: Mar 2022.
Phraxis Funding Rounds
Phraxis Founders and Leadership Team
No contact details are on record for this team yet.
Phraxis Funding Compared to Other Health Care Startups
Phraxis' latest round of $4.5M is in line with the median round in Health Care. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Phraxis in Health Care and Saint Paul
Companies Similar to Phraxis
Using technology and the best professionals, Wally, a membership-based dental care service, offers proactive,…
PreciseDx is a unique Cancer Risk Stratification company that offers personalized risk information by…
General Medicine provides a convenient and straightforward way to access top-quality healthcare services with…
Forty million men in the US and over 500 million worldwide suffer from urinary obstruction related to benign…
SedMed provides medical devices that support safer toileting transfers and help prevent falls for individuals…
Aptatek is developing cutting edge technologies for portable disease management devices that will improve…
Flow Medical offers multi-function catheters to aid in the diagnosis and treatment of venous thromboembolic…
Light Wave Dental Management offers management services for high-quality dental offices in Virginia.…
For health care systems and payers focused on improving maternal outcomes and health equity, our product is a…
Tempo Therapeutics creates materials that are designed for regenerative medicine, with a focus on being…
Vibronix was established by Dr. Ji-Xin Cheng and Dr. Pu Wang at Purdue University with the goal of offering…
People with chronic diseases can live their best lives thanks to Vheda Health. We concentrate on three areas…
Phraxis Funding FAQs
What does Phraxis do?
Phraxis is a medical device company, develops treatment solutions for patients who need vascular access to enable hemodialysis. The company offers InterGraft, a percutaneously delivered arterio-venous shunt that provides a non-surgical approach for patients who need vascular access. It also develops devices for interventional nephrology to enable physicians to manage their dialysis patients. The company was incorporated in 2008 and is based in St. Paul, Minnesota.
How much funding has Phraxis raised?
Phraxis has raised $4.5M across 1 round on record. The most recent is a Series D of $4.5M announced in Mar 2022.
When did Phraxis last raise funding?
Phraxis' most recent funding round on record is a Series D of $4.5M, announced in Mar 2022.
Who is the CEO of Phraxis?
Michael Kallok is listed as CEO at Phraxis.
Where is Phraxis headquartered?
Phraxis is based in Saint Paul, Minnesota, United States.
How many employees does Phraxis have?
Phraxis is in the 1-10 employee band.
How does Phraxis' funding compare to other Health Care startups?
Phraxis' latest round of $4.5M is in line with the $4.9M median round size for Health Care companies on FundedIQ across 3,659 tracked companies over the last two years.
About FundedIQ's Phraxis Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Phraxis is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.